| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.24B | 1.15B | 1.10B | 1.03B | 957.04M | 1.20B |
| Gross Profit | 531.45M | 450.75M | 443.09M | 413.74M | 372.73M | 496.66M |
| EBITDA | 77.50M | 37.50M | 358.55M | -19.67M | -63.67M | 82.08M |
| Net Income | 102.62M | 42.81M | 228.96M | -44.04M | -111.83M | 46.18M |
Balance Sheet | ||||||
| Total Assets | 1.51B | 1.55B | 1.48B | 1.32B | 1.35B | 1.33B |
| Cash, Cash Equivalents and Short-Term Investments | 1.14B | 1.11B | 1.20B | 769.49M | 811.06M | 980.10M |
| Total Debt | 1.75M | 2.27M | 4.32M | 6.29M | 0.00 | 0.00 |
| Total Liabilities | 309.74M | 366.19M | 337.30M | 260.45M | 243.77M | 243.75M |
| Stockholders Equity | 1.20B | 1.19B | 1.15B | 1.06B | 1.11B | 1.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -26.99M | -41.29M | -48.04M | -156.42M | 863.00K |
| Operating Cash Flow | 0.00 | -20.06M | -25.93M | -41.21M | -151.49M | 47.43M |
| Investing Cash Flow | 0.00 | -66.37M | 459.15M | 3.72M | 1.52M | -51.54M |
| Financing Cash Flow | 0.00 | -2.05M | -1.97M | -4.08M | -19.08M | 296.87M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥35.54B | 16.09 | 19.71% | 3.09% | 3.44% | 79.35% | |
68 Neutral | ¥25.30B | 20.45 | ― | ― | 6.33% | 14.82% | |
68 Neutral | ¥32.40B | 24.33 | ― | 0.39% | 30.59% | 65.14% | |
67 Neutral | ¥16.26B | 20.22 | ― | 0.17% | 31.39% | 13.12% | |
65 Neutral | ¥39.10B | 31.12 | ― | 0.90% | 25.06% | 37.24% | |
62 Neutral | ¥2.45B | 32.27 | ― | 0.58% | 25.37% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
SecuAvail reported net sales of ¥906 million for the nine months ended December 31, 2025, up 8.9% year on year, swinging from a loss to a ¥27 million profit attributable to owners of the parent as margins improved. The company’s balance sheet remained solid, with total assets of ¥1,503 million and an equity ratio of 80.1%, while it reaffirmed its full-year outlook calling for ¥1,320 million in sales, sharply higher operating profit, and a planned increase in the annual dividend to ¥5 per share, signaling confidence in earnings recovery.
The forecast for the fiscal year ending March 31, 2026 implies a 14.9% rise in sales and more than a tripling of operating profit, which, if achieved, would mark a strong earnings turnaround after prior weakness. For stakeholders, the combination of improving profitability, a stronger equity position, and a higher dividend payout suggests the company is transitioning from a period of muted performance to renewed growth, potentially enhancing its standing in the domestic small-cap tech and security space.
The most recent analyst rating on (JP:3042) stock is a Hold with a Yen400.00 price target. To see the full list of analyst forecasts on SecuAvail, Inc. stock, see the JP:3042 Stock Forecast page.
SecuAvail Inc. announced that, in addition to its existing marginable status on the Tokyo Stock Exchange Standard Market, its shares have been newly designated as marginable securities on the Sapporo Securities Exchange’s Main Market, effective February 18, 2026, coinciding with its listing date there. The company expects the dual margin trading designation to boost liquidity, expand investor participation, and promote more active trading and efficient price discovery, reinforcing its efforts to strengthen its capital markets presence and support long-term value for shareholders.
By becoming margin-eligible on both Tokyo and Sapporo exchanges, SecuAvail is seeking to deepen engagement with a wider range of market participants and facilitate smoother trading of its stock. This step underscores the company’s strategy to leverage its exchange listings to enhance visibility and trading dynamics, potentially making the shares more attractive to both retail and institutional investors over time.
The most recent analyst rating on (JP:3042) stock is a Hold with a Yen400.00 price target. To see the full list of analyst forecasts on SecuAvail, Inc. stock, see the JP:3042 Stock Forecast page.
SecuAvail Inc. has received approval for a dual listing on the Main Board of the Sapporo Securities Exchange, with trading scheduled to begin on February 18, 2026, in addition to its existing listing on the Tokyo Stock Exchange Standard Market. The company aims to use the Sapporo listing to boost recognition in the Hokkaido region, deepen ties with local individual investors and companies, expand regional business activities, and reinforce its governance and investor-relations framework, with the broader goal of enhancing corporate value and delivering sustainable, medium- to long-term growth for stakeholders as its shares become tradable on both markets.
The most recent analyst rating on (JP:3042) stock is a Hold with a Yen403.00 price target. To see the full list of analyst forecasts on SecuAvail, Inc. stock, see the JP:3042 Stock Forecast page.
SecuAvail Inc. has received approval from the Tokyo Stock Exchange to transfer its listing from the Growth Market to the Standard Market, with the change taking effect on January 21, 2026 and the share transfer scheduled for January 28, 2026. The company, which fully meets all listing maintenance criteria for the Standard Market, has withdrawn its previous plan to comply with Growth Market requirements and says the move will support its long-term, subscription-based network security business while reinforcing its commitment to capital-efficiency-focused management, medium-term growth targets, and the broader social responsibilities expected of a provider of infrastructure-grade security services.
The most recent analyst rating on (JP:3042) stock is a Hold with a Yen409.00 price target. To see the full list of analyst forecasts on SecuAvail, Inc. stock, see the JP:3042 Stock Forecast page.